Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Sep
9
2014
FDA Issues Draft Guidance Regarding Controlled Correspondence from Generics Manufacturers Mintz
Sep
9
2014
Decision Requiring Commercial-Item Suppliers to Comply with Non-Standard Terms under the Federal Acquisition Regulation (FAR) Is Stayed Pending Appeal at Federal Circuit Covington & Burling LLP
Sep
8
2014
Wage & Hour Claims: A Look Back on the First Half of 2014 Gilbert LLP
Sep
5
2014
Australia: Cancer Voices v Myriad Opinion Affirmed
Sep
5
2014
Telehealth and Health IT Policy: Considerations for Stakeholders Mintz
Sep
3
2014
Government Issues New Rules for Religious Employers, But Health Plans, Third Party Administrators (TPAs), and Pharmacy Benefits Managers (PBMs) are still on the Hook to Provide Contraceptive Coverage Mintz
Sep
2
2014
EU Court Of Justice Further Clarifies Definition Of Medicinal Products – And Raises New Questions Covington & Burling LLP
Sep
2
2014
China Issues Multiple Final Rules and Proposals to Implement Recent Revisions to its Core Medical Device Regulation Covington & Burling LLP
Sep
2
2014
Summary of FDA Advertising and Promotion Enforcement Activities – September 2, 2014 Covington & Burling LLP
Sep
2
2014
The Increasingly Murky World of 340B Drug Discount Program: What’s Next? Mintz
Sep
2
2014
Two-Party Market: Presumption of Confusion and Injury McDermott Will & Emery
Aug
29
2014
Pharmacies Avoid False Claims Act Suit: Fox Rx Inc. v. Omnicare Inc. et al. Covington & Burling LLP
Aug
28
2014
Hawaii G-M-O: Kauai County GMO Regs Struck Down in Federal Court Mintz
Aug
28
2014
Third Circuit Holds Irreparable Harm May Not Be Presumed In Lanham Act False Advertising Cases To Establish Entitlement To Injunctive Relief Proskauer Rose LLP
Aug
27
2014
Genus Claims Require Disclosure of “Representative Species Encompassing the Breadth of the Genus” McDermott Will & Emery
Aug
27
2014
Selection Invention Found Unpatentable for Obviousness-Type Double Patenting Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
27
2014
Tennessee Employer Gets New Trial to Prove Drug Tests Were Not Medical Examinations or Disability-Related Inquiries Jackson Lewis P.C.
Aug
26
2014
Health Care Law Update - August 25, 2014 Mintz
Aug
25
2014
Northern District of Illinois Court Answers the Question: What KIND of Juice Did They Say It Was? Proskauer Rose LLP
Aug
25
2014
FDA Notifies Congress of Framework for Long-Awaited Guidance on Laboratory Developed Tests and Issues Final Guidance on Companion Diagnostics Mintz
Aug
25
2014
FDA Issues Draft Guidance on De Novo Process Barnes & Thornburg LLP
Aug
25
2014
Medical Device Update: FDA Issues Draft Guidance on Streamlined De Novo Classification Process Morgan, Lewis & Bockius LLP
Aug
25
2014
Prescription Drugs: Refocusing the False Claims Act Microscope on the Rest of the Transaction Mintz
Aug
25
2014
Physicians Write Letter to FDA Regarding Biosimilar Naming Concerns McDermott Will & Emery
Aug
25
2014
FDA’s Announced Framework for Regulating Laboratory Developed Tests (LDTs) Leaves Open Many Questions Covington & Burling LLP
Aug
22
2014
Office of Inspector General (OIG) Finds Risk of Abuse in Specialty Pharmacy’s Per-Fill Fee Proposal Mintz
Aug
22
2014
Pennsylvania Federal Judge Upholds Poaching Claims in Pharmaceutical Data Antitrust Case McDermott Will & Emery
Aug
21
2014
Liquor License Lottery Drawing Application Period Opens for Florida Lowndes, Drosdick, Doster, Kantor & Reed, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins